Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer
Yu-Yun Shao, Wen-Yi Shau, Zhong-Zhe Lin, Ho-Min Chen, Raymond Kuo, James Chih-Hsin Yang, Mei-Shu LaiТом:
49
Рік:
2013
Мова:
english
DOI:
10.1016/j.ejca.2012.07.014
Файл:
PDF, 943 KB
english, 2013